Alkermes (ALKS) Non-Current Debt (2011 - 2026)
Alkermes (ALKS) reported Non-Current Debt of $1.5 billion for Q1 2026, up 419.15% quarter-over-quarter from $285.8 million in Q3 2024.
Alkermes (ALKS) Non-Current Debt (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 15 years of Non-Current Debt data on file, last reported at $1.5 billion in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $1.5 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (changed N/A YoY), and the FY2023 annual result was $287.7 million, down 0.88% from the prior year.
- Non-Current Debt grew to $1.5 billion in Q1 2026 per ALKS's latest filing, from $285.8 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $1.5 billion in Q1 2026 and troughed at $285.8 million in Q3 2024.
- A 4-year average of $388.6 million and a median of $289.3 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2024: Non-Current Debt retreated 0.86% in 2022, then retreated 0.88% in 2024.
- A 4-year view of Non-Current Debt shows it stood at $290.3 million in 2022, then decreased by 0.88% to $287.7 million in 2023, then declined by 0.66% to $285.8 million in 2024, then jumped by 419.15% to $1.5 billion in 2026.
- Business Quant data shows ALKS's Non-Current Debt at $1.5 billion in Q1 2026, $285.8 million in Q3 2024, and $286.5 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Bn |
| Mar 31, 2026 | 1.48 Bn |
| Sep 30, 2024 | 285.82 Mn |
| Sep 30, 2024 | 285.82 Mn |
| Jun 30, 2024 | 286.46 Mn |
| Jun 30, 2024 | 286.46 Mn |
| Mar 31, 2024 | 287.10 Mn |
| Mar 31, 2024 | 287.10 Mn |
| Dec 31, 2023 | 287.73 Mn |
| Dec 31, 2023 | 287.73 Mn |
| Sep 30, 2023 | 288.37 Mn |
| Sep 30, 2023 | 288.37 Mn |
| Jun 30, 2023 | 289.00 Mn |
| Jun 30, 2023 | 289.00 Mn |
| Mar 31, 2023 | 289.64 Mn |
| Mar 31, 2023 | 289.64 Mn |
| Dec 31, 2022 | 290.27 Mn |
| Dec 31, 2022 | 290.27 Mn |
| Sep 30, 2022 | 290.90 Mn |
| Sep 30, 2022 | 290.90 Mn |